Supplementary Date (For Publication) from Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression
Authors:
- Heather NesbittHNHeather Nesbitt
- Niall M. ByrneNBNiall M. Byrne
- S. Nicole WilliamsSWS. Nicole Williams
- Louise MingLMLouise Ming
- Jenny WorthingtonJWJenny Worthington
- Rachel J. ErringtonRERachel J. Errington
- Laurence H. PattersonLPLaurence H. Patterson
- Paul J. SmithPSPaul J. Smith
- Stephanie R. McKeownSMStephanie R. McKeown
- Declan J. McKennaDMDeclan J. McKenna
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)